[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20020837D0 - Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer - Google Patents

Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer

Info

Publication number
NO20020837D0
NO20020837D0 NO20020837A NO20020837A NO20020837D0 NO 20020837 D0 NO20020837 D0 NO 20020837D0 NO 20020837 A NO20020837 A NO 20020837A NO 20020837 A NO20020837 A NO 20020837A NO 20020837 D0 NO20020837 D0 NO 20020837D0
Authority
NO
Norway
Prior art keywords
prostaglandin
receptor
receptors
identifying properties
substance
Prior art date
Application number
NO20020837A
Other languages
English (en)
Other versions
NO20020837L (no
Inventor
Hiroyuki Hirai
Kazuyuki Ogawa
Kinya Nagata
Syoichi Takano
Original Assignee
Bml Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bml Inc filed Critical Bml Inc
Publication of NO20020837D0 publication Critical patent/NO20020837D0/no
Publication of NO20020837L publication Critical patent/NO20020837L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO20020837A 1999-08-23 2002-02-20 Fremgangsmåte for å identifisere et stoffs egenskaper hensyn til humane prostaglandin D-reseptorer NO20020837L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23620799 1999-08-23
JP2000153172 2000-05-24
PCT/JP2000/005615 WO2001014882A1 (fr) 1999-08-23 2000-08-22 Identification des proprietes d'une substance pour les recepteurs de prostaglandine d

Publications (2)

Publication Number Publication Date
NO20020837D0 true NO20020837D0 (no) 2002-02-20
NO20020837L NO20020837L (no) 2002-04-22

Family

ID=26532542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020837A NO20020837L (no) 1999-08-23 2002-02-20 Fremgangsmåte for å identifisere et stoffs egenskaper hensyn til humane prostaglandin D-reseptorer

Country Status (9)

Country Link
US (1) US6884593B1 (no)
EP (1) EP1211513B1 (no)
JP (1) JP3486408B2 (no)
AT (1) ATE315230T1 (no)
AU (1) AU772121B2 (no)
CA (1) CA2383135C (no)
DE (2) DE1211513T1 (no)
NO (1) NO20020837L (no)
WO (1) WO2001014882A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878522B2 (en) * 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
WO2003030616A2 (en) * 2001-10-10 2003-04-17 Millennium Pharmaceuticals, Inc. 21132, a human g-protein coupled receptor family member and uses therefor
WO2003097042A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Antagoniste de recepteur de pdg2
WO2003097598A1 (fr) * 2002-05-16 2003-11-27 Shionogi & Co., Ltd. Composé comprenant un antagonisme du récepteur de pdg2
BR0317591A (pt) 2002-12-20 2005-11-22 Amgen Inc Composto, sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, métodos para tratar uma doença ou condição, para modular a função de crth2 e/ou um ou mais outros receptores de pgd2 em uma célula e para modular crth2 e/ou um ou mais outros receptores de pgd2
SE0301010D0 (sv) 2003-04-07 2003-04-07 Astrazeneca Ab Novel compounds
SA04250253B1 (ar) 2003-08-21 2009-11-10 استرازينيكا ايه بي احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SI1725553T1 (sl) 2004-03-11 2008-08-31 Actelion Pharmaceuticals Ltd Derivati tetrahidropiridoindola
EP1740179A1 (en) * 2004-04-20 2007-01-10 Pfizer Limited Method of treating neuropathic pain using a crth2 receptor antagonist
GB0415320D0 (en) 2004-07-08 2004-08-11 Astrazeneca Ab Novel compounds
GB0418830D0 (en) 2004-08-24 2004-09-22 Astrazeneca Ab Novel compounds
UY29223A1 (es) 2004-11-23 2006-06-30 Astrazeneca Ab Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación
TW200745003A (en) 2005-10-06 2007-12-16 Astrazeneca Ab Novel compounds
EP1937632A1 (en) 2005-10-06 2008-07-02 Astra Zeneca AB Novel compounds
JP5270542B2 (ja) 2006-07-22 2013-08-21 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
UA100983C2 (ru) 2007-07-05 2013-02-25 Астразенека Аб Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
WO2009061681A2 (en) * 2007-11-06 2009-05-14 Amira Pharmaceuticals, Inc Antagonists of pgd2 receptors
WO2009061676A2 (en) * 2007-11-06 2009-05-14 Amira Pharmaceuticals, Inc. Antagonists of pgd2 receptors
EP2231595B1 (en) 2007-12-19 2014-04-23 Amgen, Inc Phenyl acetic acid derivatives as inflammation modulators
KR101644170B1 (ko) 2008-01-18 2016-08-01 옥사겐 리미티드 씨알티에이치2 길항제 활성을 갖는 화합물
EP2240444A1 (en) 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
GB2460597B8 (en) * 2008-02-01 2014-03-12 Amira Pharmaceuticals Inc N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors
CN101952244B (zh) 2008-02-01 2014-11-05 潘米拉制药公司 前列腺素d2受体的n，n-二取代氨基烷基联苯拮抗剂
WO2009102893A2 (en) * 2008-02-14 2009-08-20 Amira Pharmaceuticals, Inc. CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors
WO2009108720A2 (en) * 2008-02-25 2009-09-03 Amira Pharmaceuticals, Inc. Antagonists of prostaglandin d2 receptors
WO2009145989A2 (en) * 2008-04-02 2009-12-03 Amira Pharmaceuticals, Inc. Aminoalkylphenyl antagonists of prostaglandin d2 receptors
BRPI0913930A2 (pt) * 2008-07-03 2015-10-20 Amira Pharmaceuticals Inc antagonistas de receptores de prostaglandinas d2
GB2463788B (en) * 2008-09-29 2010-12-15 Amira Pharmaceuticals Inc Heteroaryl antagonists of prostaglandin D2 receptors
WO2010039977A2 (en) 2008-10-01 2010-04-08 Amira Pharmaceuticals, Inc. Heteroaryl antagonists of prostaglandin d2 receptors
US8524748B2 (en) 2008-10-08 2013-09-03 Panmira Pharmaceuticals, Llc Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors
US8383654B2 (en) 2008-11-17 2013-02-26 Panmira Pharmaceuticals, Llc Heterocyclic antagonists of prostaglandin D2 receptors
US20100173313A1 (en) * 2009-01-08 2010-07-08 Amira Pharmaceuticals, Inc. Biomarkers of inflammation
EP2461809A4 (en) 2009-07-31 2013-06-19 Panmira Pharmaceuticals Llc OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONSITES
JP2013501052A (ja) * 2009-08-05 2013-01-10 パンミラ ファーマシューティカルズ，エルエルシー． Ｄｐ２アンタゴニストおよびその用途
JP2013516475A (ja) 2010-01-06 2013-05-13 アミラ ファーマシューティカルズ，インク． Ｄｐ２アンタゴニストおよびその使用
GB201103837D0 (en) 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
EP2912458B1 (en) 2012-10-24 2018-07-18 NYU Winthrop Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
WO2019055661A1 (en) 2017-09-13 2019-03-21 Progenity, Inc. PRE-ÉCLAMPSIE BIOMARKERS AND ASSOCIATED SYSTEMS AND METHODS
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69734141T2 (de) * 1996-06-05 2006-07-13 Bml Inc. PROTEIN, DAS FÜR MENSCHLICHE Th2-ZELLEN SPEZIFISCH IST, DAFÜR KODIERENDES GEN UND KORRESPONDIERENDE TRANSFORMANTE, REKOMBINANTER VEKTOR UND MONOKLONALER ANTKÖRPER
US6878522B2 (en) * 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2

Also Published As

Publication number Publication date
WO2001014882A1 (fr) 2001-03-01
US6884593B1 (en) 2005-04-26
DE60025368D1 (de) 2006-03-30
NO20020837L (no) 2002-04-22
ATE315230T1 (de) 2006-02-15
DE60025368T2 (de) 2006-09-14
CA2383135A1 (en) 2001-03-01
EP1211513A1 (en) 2002-06-05
AU6598800A (en) 2001-03-19
EP1211513A4 (en) 2003-04-16
CA2383135C (en) 2010-11-30
AU772121B2 (en) 2004-04-08
DE1211513T1 (de) 2002-11-14
EP1211513B1 (en) 2006-01-04
JP3486408B2 (ja) 2004-01-13

Similar Documents

Publication Publication Date Title
NO20020837D0 (no) Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer
NO983431L (no) Anti-klöemidler
NO20010446L (no) Substituert anilidforbindelser og metoder
PT1333887E (pt) Metodo de tratamento de desordens musculares
DK1199069T3 (da) Anvendelse af en estrogenagonist/-antagonist til forbedring eller bibeholdelse af urogenital sundhed
PT800519E (pt) Compostos moduladores de receptores de esteroides e metodos
AUPO755097A0 (en) Receptor agonist and antagonist
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
PT841928E (pt) Formulacao de libertacao prolongada de d-trep-metilfenidato
BR9710988A (pt) Método e compostos moduladores receptores de androgênio
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
TR199700956T1 (xx) Indazolkarboksamidler.
ES2162936T3 (es) Tratamiento de la ansiedad.
WO2003072558A3 (en) Arylsulfone derivatives
DK0730865T3 (da) Anvendelse af serotonin- og dopaminreceptor-blokkere til behandling af sindslidelser, som skyldes cerebrovasculær sygdom
DE60135130D1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
ATE432350T1 (de) G-protein gekoppelte rezeptoren
NO20043371L (no) Kortikotropinfrigjorendefaktorreseptor-2 agonister
DE60033576D1 (de) Methoden zum screening knochenmorphogenetishemimetika
NO20062915L (no) Fremgangsmate til a identifisere modulatorer av aktiv KIT tyrosinkinase reseptor
NO20064354L (no) Fremgangsmate for bestemmelse av sympatisk tonus og system for maling derav
EA200100182A1 (ru) Лечение состояний тревожности
MXPA04010915A (es) Base y procedimiento de conocimiento de recursos humanos dinamicos.
TR199701613T1 (xx) Selim prostatik hiperplasyan�n tedavisi i�in melatonin agonistleri.
NO992850D0 (no) Polymer basert pÕ et konjugert dien og en dienofil komponent